4.5 Editorial Material

Essential medicines lists are for high income countries too

Related references

Note: Only part of the references are listed.
Article Health Care Sciences & Services

Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees

Elkanah Linder et al.

Summary: The Swedish Drug and Therapeutics Committees (DTCs) find the knowledge supports for environmental information on pharmaceuticals valuable, but they face challenges in their work, including lack of data, lack of transparency from the pharmaceutical industry, and difficulties considering the environmental aspect of pharmaceuticals in their healthcare practice. The study can provide insights to other countries interested in addressing environmental aspects in their formulary decision-making.

BMC HEALTH SERVICES RESEARCH (2023)

Editorial Material Health Policy & Services

Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation

Petra Brhlikova et al.

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2023)

Article Medicine, General & Internal

Inhaled anaesthesia and analgesia contribute to climate change

Jodi D Sherman et al.

BMJ-British Medical Journal (2022)

Article Medicine, General & Internal

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study

Michael Sergio Taglione et al.

Summary: Essential medicines lists of high-income countries are similar to each other, but significant variations in essential medicine list composition and specifically the number of medications included were noted. Effective medicines were left off several countries' lists, and globally recalled medicines were included on over half the lists. Comparing the essential medicines lists of countries within the same income status category can provide a useful subset of lists for policymakers and essential medicine list creators to use when creating or maintaining their lists.

BMJ OPEN (2021)

Article Public, Environmental & Occupational Health

Comparison of essential medicines lists in 137 countries

Nav Persaud et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2019)

Article Health Care Sciences & Services

Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the Need Clause

Bard Hobaek et al.

MILBANK QUARTERLY (2019)

Editorial Material Medicine, General & Internal

Pharmaceutical research and development: what do we get for all that money?

Donald W. Light et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

Article Social Sciences, Biomedical

Making medicines essential: The emergent centrality of pharmaceuticals in global health

Jeremy A. Greene

BIOSOCIETIES (2011)

Article Medicine, General & Internal

The concept of essential medicines: lessons for rich countries

HV Hogerzeil

BRITISH MEDICAL JOURNAL (2004)